3419 results for «2024»
3419 results
Artificial intelligence (AI) in interventional cardiology
16 May 2024 – From EuroPCR 2024
Watch this discussion with Jan McCloud, Bram Van Ginneken, Niels Van Royen, and Richard Rapoza as they distinguish between artificial intelligence (AI) and machine learning, explore AI's impact on interventional cardiology, and Abbott's integration of AI. They also delve into AI's challenges, including algorithm development complexities...
EARTH-STEMI - Complete vs. culprit-only revascularisation in older STEMI patients
03 Sep 2024
Aaysha Cader interviews Gianluca Campo about the EARTH-STEMI trial he presented at ESC Congress 2024 in London.
This meta-analysis aimed to evaluate a large cohort of STEMI patients, predominantly comorbid, with a mean age of 79 and extended long-term follow-up. The key findings revealed that complete revascularisation reduced the...
Author
Author
How can multi modality imaging contribute to the assessment of multivalve disease?
25 Nov 2024 – From PCR London Valves 2024
Interested in how multi-modality imaging aids in evaluating? Joao Cavalcante and Madalina Garbi explore the challenges of relying solely on echocardiography for diagnosing multivalve disease and explain how techniques like CT and MRI improve the accuracy of assessing valve severity, heart chamber remodeling and support decision-making...
RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
01 Sep 2024
Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.
The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...
Author
Acute coronary syndromes: summary of the 2023 ESC Guidelines - a new chapter in The PCR Textbook
18 Jun 2024 – From EuroPCR 2024
Join Piera Capranzano and Robert Byrne in this video to delve into the new chapter of The PCR Textbook on the 2023 ESC guidelines for acute coronary syndromes. This chapter highlights key points for interventional cardiologists, focusing on invasive management, antiplatelet and anti-thrombotic therapy, and revascularization...
Focus on EAPCI PCR Fellows Course
18 Jun 2024 – From EuroPCR 2024
In celebration of the tenth anniversary of the EAPCI PCR Fellows Course, Gabor Toth interviews Chiara De Biase about the initial target participants of the Course, the topics covered during this one-day event, and the decision to exclude structural topics to promote the PCR London Valves...
MitraClip sets a new standard for TEER therapy based on the EXPAND G4 data in Japan
20 Mar 2024 – From PCR Tokyo Valves 2024
This video discusses the results of the Expand G4 trial conducted in Japan, focusing on the use of MitraClip for transcatheter edge-to-edge repair therapy. Interviewed by Mike Saji, Masahiko Asami presents data showing a high success rate in Japanese patients, with significant reductions in mitral regurgitation...
Focus on Jon DeHaan Foundation Award for Innovation in Cardiology
18 Jun 2024 – From EuroPCR 2024
Join Tom DeHaan, Rishi Puri, and Robert Schwartz as they delve into the history and purpose of the Jon DeHaan Foundation. Learn about the prestigious award's latest winner, the A-FLUX coronary sinus reducer, and the journey that led to this achievement. Discover how recognizing innovative and...
Early detection and treatment of aortic stenosis
25 Nov 2024 – From PCR London Valves 2024
Want to learn about the latest advancements in the early detection and treatment of aortic stenosis? Mayra Guerrero and Philippe Genereux discuss the benefits of early intervention (even in asymptomatic patients), the optimal timing for treatment and explore how artificial intelligence can enhance diagnosis, particularly in...
How to manage the complexity of multivalve disease?
17 Apr 2025 – From PCR London Valves 2024
Curious about how to manage the complexities of multivalve disease? Tiffany Patterson and Philipp Lurz share their approach to treating patients with multiple valve issues (aortic stenosis, mitral regurgitation, tricuspid regurgitation...) and discuss strategies for deciding which valve to treat first, the challenges of managing these...
What is the optimal TAVI access approach in contemporary practice?
14 May 2025 – From PCR London Valves 2024
What is the optimal TAVI access approach in today’s practice? Ole De Backer and Maarten Vanhaverbeke break down the latest evidence and trends in TAVI access. Watch this video to learn about the dominance of transfemoral access, the role of alternative routes like transcarotid and transaxillary,...
Nurses and Allied Professionals: How to safely discharge your patient post TAVI?
10 Feb 2025 – From PCR London Valves 2024
What does it take to ensure a smooth, safe, and confident discharge for TAVI patients? Sarah Carson and Gemma McCalmont share valuable insights and practical strategies. From pre-assessment planning and early mobilization to managing complications and preparing patients for recovery, this video offers essential tips for...
What do we know about bleeding risk & antithrombotic management after tricuspid valve interventions?
26 Nov 2024 – From PCR London Valves 2024
How do we navigate the thin line between bleeding risk and thrombosis in high-risk patients undergoing tricuspid valve interventions? Marianna Adamo and Fabien Praz explore the latest strategies in anticoagulation, the challenges of managing complex cases and how cutting-edge research is shaping the future of care....
Nurses and Allied Professionals: How does frailty and cognition impact patient selection for TAVI?
26 Nov 2024 – From PCR London Valves 2024
How do frailty and cognitive function shape patient selection for TAVI? Karen Wilson and Lynne Hinterbuchner discuss the essential role of screening and assessment in identifying suitable candidates, highlighting tools like the Edmonton scale and emphasizing the importance of a multidisciplinary approach to prehabilitation.
This interview was...
Insights from real-world and post-market evidence on Tricuspid TEER
26 Nov 2024 – From PCR London Valves 2024
In this video, Mirjam Wild, Tobias Kister, and Jonathan Byrne discuss real-world evidence from transcatheter edge-to-edge repair, focusing on the TriCLASP and PACE registries. These studies evaluate the PASCAL Precision system for tricuspid regurgitation and its impact on clinical practice.
This interview was filmed at PCR London...
TRISCEND II Pivotal Trial : How will TTVR impact the treatment of tricuspid regurgitation?
25 Nov 2024 – From PCR London Valves 2024
In this roundtable discussion, Marianna Adamo, Philipp Lurz, and Sam Dawkins explore the one-year outcomes of the TRISCEND II Pivotal Trial, highlighting its potential to redefine the management of severe tricuspid regurgitation. They delve into the trial’s impact on patients’ quality of life, examine its limitations,...
How the latest recommendations on MINOCA can impact our practice
14 May 2024 – From EuroPCR 2024
Join Vijay Kunadian and Salvatore Brugaletta as they talk about the latest ESC guidelines for MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries). Together, they review the crucial aspects of identifying MINOCA patients, how to diagnose them effectively using available diagnostic tools and the importance of post-treatment...
ShortCut leads the way for leaflet modification
14 May 2024 – From EuroPCR 2024
Check out this interview with Philippe Genereux, Danny Dvir and Susheel Kodali, where they discuss the ShortCut trial. Learn about the ShortCut device, the first tool for splitting leaflets in valve-in-valve procedures. Hear key insights, including the dual splitting technique, comparisons between BASILICA and ShortCut, and...
Drug-coated balloon PCI for de novo lesions: when and how?
15 May 2024 – From EuroPCR 2024
Michael Haude and Michael Lee discuss various aspects of DCB PCI, emphasizing lesion preparation, dissection management, and the role of imaging and physiology. They touch upon ongoing studies comparing DCB PCI with DES PCI, consider the duration of DAPT in ACS and non-ACS cases, and explore...
What are the key considerations for first-time TAVI in a patient with long life expectancy?
15 May 2024 – From EuroPCR 2024
Interviewed by Dan Blackman, Philip Maccarthy discusses the rising trend of TAVI in younger patients and emphasizes optimizing first-TAVI procedure outcomes for long-term durability. He highlights considerations such as haemodynamics, low gradient, and minimizing paravalvular leak (PVL), as well as the importance of coronary access and...
